Vbi Vaccines Inc CS (VBIV)

$0.63 0.02 (3.28%)

14:28 EDT VBIV Stock Quote Delayed 30 Minutes

VBIV Stock Earnings: VBI Vaccines Beats EPS, Misses Revenue for Q4 2023

By InvestorPlace Earnings Apr 16, 2024

VBIV stock results show that VBI Vaccines beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

7 Biotech Stocks to Sell in July

Why Is VBI Vaccines (VBIV) Stock Down 40% Today?

Volume:

Previous Close -

Market Cap 17.91M

PE Ratio -0.13

EPS -4.92

Volume (Avg. Vol.) 155,613

Day's Range $0.58 - $0.64

52-Week Range $0.45 - $3.86

Dividend & Yield N/A (N/A)

VBIV Stock Predictions, Articles, and Vbi Vaccines Inc CS News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Jul 6, 2023

It's time to start the day off right with a breakdown of the biggest pre-market stock movers traders need to watch on Thursday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Jan 5, 2023

We're starting off the day with a breakdown of the biggest pre-market stock movers for Thursday that traders need to know about!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Jul 13, 2022

Good morning, investors! We're starting off the day with a breakdown of the biggest pre-market stock movers for Wednesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Dec 7, 2021

Good morning, trader! We're beginning another busy day of trading with a breakdown of the biggest pre-market stock movers for Tuesday!

VBIV Stock Is Shooting Higher on Big FDA Vaccine Approval News

By Samuel O'Brient, InvestorPlace Reporter Dec 1, 2021

VBI Vaccines just got the green light from the FDA for its new Hepatitis B vaccine. VBIV stock is reacting well so far today.

7 Penny Stocks Waiting on the FDA for Rocket Fuel

By Thomas Niel, InvestorPlace Contributor Sep 9, 2021

News of regulatory approval or progress would really help to move the needle for these seven biotech penny stocks.

8 Biotech Penny Stocks for Investors to Watch

By Thomas Niel, InvestorPlace Contributor Mar 10, 2021

Low-priced biotechs have sold off recently, but there could still be potential in these picks. Here are eight penny stocks to consider.

8 Penny Stocks to Avoid in 2021

By Thomas Niel, InvestorPlace Contributor Jan 11, 2021

With risk-return not in your favor, steer clear of these 8 penny stocks, all of which could see big declines as the new year unfolds. Chesapeake Energy (OTCMKTS:CHKAQ) Genius Brands (NASDAQ:GNUS) Hertz Global Holdings (OTCMKTS:HTZGQ) Remark Holdings (NASDAQ:MARK) Ocugen (NASDAQ:OCGN) StoneMor (NYSE:STON) VBI Vaccines (NASDAQ:VBIV) XspresSpa (NASDAQ:XSPA)

7 Short-Term Stocks to Make a Quick Buck

By Josh Enomoto, InvestorPlace Contributor Oct 16, 2020

It wasn’t just toilet paper that was in demand when Covid-19 hit us as short-term stocks flew through the roof. But with a second wave upon us, this narrative looks very compelling.

While Risks Remain, VBI Vaccines Stock Is a Buy at Today’s Prices

By Thomas Niel, InvestorPlace Contributor Feb 5, 2020

Sci-B-Vac's success will make or break VBIV stock. But the shares' recent pullback may have created a great buying opportunity.

5 Stocks Under $5 With Colossal Growth Prospects

By Maya Sasson, Writer, TipRanks Jan 31, 2020

While some argue you get what you pay for, others say that stocks trading at low levels can represent compelling opportunities.

Is It Time to Go Long on VBIV Stock?

By Chris Markoch, InvestorPlace Contributor Jan 30, 2020

As a speculative pharmaceutical investment, VBIV stock is not for the faint of heart. However, the underlying business suggests some rationale for longer-term optimism.

VBI Vaccines News: VBIV Stock Skyrockets 17% on Clinical Trial Success

By William White, InvestorPlace Writer Jan 13, 2020

VBI Vaccines (VBIV) news for Monday about results from a recent clinical trial of a hepatitis B vaccine have VBI stock soaring.

5 Stocks to Buy Based on Insider Buying

By Mark Putrino, CMT Oct 8, 2019

These are five stocks to consider buying because of significant insider buying activity. Insiders only buy for one reason: to make money.

3 Pivotal Drug Trials to Watch for Explosive Potential

By Samuel Rae, InvestorPlace Contributor Jun 29, 2017

Here's a look at three biotech stocks that have at least one treatment prepped to enter pivotal clinical trials soon.

VBI signs deal to sell manufacturing capabilities, certain assets with Brii Biosciences

From Seeking Alpha Feb 14, 2024

Biopharmaceutical firm VBI Vaccines rose over 7% in premarket trading as Brii Biosciences announced the acquisition of VBI's HBV immunotherapeutic...

VBI Vaccines stock gains after data for Hep B candidate

From Seeking Alpha Sep 6, 2023

Read why VBI Vaccines (VBIV) traded higher Wednesday after its partner Brii Biosciences Limited (BRIBF), announced mid-stage data for Hep B drug BRII-179.

VBI Vaccines slides on discounted stock and warrants offering (NASDAQ:VBIV)

From Seeking Alpha Jul 6, 2023

Shares of VBI Vaccines (VBIV) tumbled 51.7% to $1.17 on Thursday after pricing its underwritten public offering and concurrent registered direct offering to cumulatively raise...

VBI Vaccines stock up on upcoming presentation on hep B shot

From Seeking Alpha Jun 7, 2023

VBI Vaccines (VBIV) added ~9% on Wednesday after the biotech announced an upcoming presentation on its Hepatitis B vaccine PreHevbrio later this month. Read more here.

VBI Vaccines To Start Clinical Study Of Pan-Coronavirus Vaccine Candidate This Year

From Benzinga Apr 5, 2022

VBI Vaccines Inc (NASDAQ: VBIV) announced

VBI Vaccines stock falls on portfolio overhaul, reverse stock split

From Seeking Alpha Apr 4, 2023

VBI Vaccines (VBIV) lost 40% on Tuesday after announcing a reverse stock split, staff reduction and plans to reorganize its portfolio. Read the full story here.

Vbi Vaccines Inc CS (VBIV)

VBIV Stock Earnings: VBI Vaccines Beats EPS, Misses Revenue for Q4 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

7 Biotech Stocks to Sell in July

Why Is VBI Vaccines (VBIV) Stock Down 40% Today?

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Vbi Vaccines Inc CS (VBIV)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

VBIV Stock Predictions, Articles, and Vbi Vaccines Inc CS News

Subscriber Sign in